In the 1940s, two prominent Yale pharmacologists, Alfred Gilman and Louis Goodman examined the therapeutic effects of mustard agents in treating lymphoma. This marked the beginning of the use of cytotoxic agents for the treatment of cancer.

Cytotoxic drugs or cytostatics are drugs used to destroy cancer cells. They act by inhibiting cell division and in this way cause cancer cells to die.  Whilst all dividing cells are affected, including those of healthy tissue, cancer cells often divide faster than normal cells, and as such the effect on normal cells is less pronounced and healthy cells will recover faster.

The drugs can be used to destroy tumours, boost the outcomes of surgery or radiotherapy, reduce metastases and alleviate cancer symptoms. Cytostatics can be effective outside the primary tumour and destroy small tumours that have not been detected in tests.

The use of cytotoxic drug treatment with different mechanisms of action has led to significant improvements in patient survival and a decline in mortality rates. This has been further enhanced by improved cancer screening and early detection, along with cause prevention by healthcare education.

The Tentamus Group is made up of class leading independent laboratories, providing high quality service and support to our clients worldwide. Our expertise covers a comprehensive and diverse portfolio of services to meet the fast-moving demands of the industry, through our dedicated laboratory locations in Europe, UK, Israel, China and the United States. Visit our website www.tentamus.com for more information.

If you have a requirement for testing of cytotoxic products, please contact one of our specialist GMP approved laboratories, who are specifically trained to handle cytotoxic products which are destined for market within the both the EU and UK.

Get in touch.

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 52 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com

Ansprechpartner:
Ian Brown
CEO Minerva Scientific Ltd
Telefon: +44 (1332) 890-384
E-Mail: ianbrown@minervascientific.co.uk
Jochen Kolb
E-Mail: jochen.kolb@bls-analytik.de
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel